PLoS ONE · 2014 · 22 citations · 17 references
ImmunologyCell DeathAntioxidant TreatmentRedox BiologyAplastic AnemiaOxidative StressFanconi AnemiaBone Marrow FailureRedox RegulatorHematologyBiochemistryReactive Oxygen SpecieMetabolomicsPharmacologyCell BiologyComparative StudyFanca CellsMetabolismMedicine
Fanconi anemia (FA) is a genetic disorder characterised by chromosome instability, cytokine ipersensibility, bone marrow failure and abnormal haematopoiesis associated with acute myelogenous leukemia. Recent reports are contributing to characterize the peculiar FA metabolism. Central to these considerations appears that cells from complementation group A (FANCA) display an altered red-ox metabolism. Consequently the possibility to improve FA phenotypical conditions with antioxidants is considered. We have characterized from the structural and biochemical point of view the response of FANCA lymphocytes to N-acetyl-cysteine (NAC) and resveratrol (RV). Surprisingly both NAC and RV failed to revert all the characteristic of FA phenotype and moreover their effects are not super imposable. Our data suggest that we must be aware of the biological effects coming from antioxidant treatment.
17
Mechanism of inhibition of bovine F <sub>1</sub> -ATPase by resveratrol and related polyphenols
Jonathan Gledhill, M.G. Montgomery, Andrew G. W. Leslie et al. · Proceedings of the National Academy of Sciences · 2007 · 374 citations · Full text
Aldo-keto Reductase, Molecular Biology, Dietary Resveratrol +17
Glutathione‐dependent reductive stress triggers mitochondrial oxidation and cytotoxicity
Huali Zhang, Pattraranee Limphong, Joel Pieper et al. · The FASEB Journal · 2011 · 190 citations · Full text
Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations
María Castellà, Roser Pujol, Elsa Callén et al. · Blood · 2011 · 136 citations